+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Berbamine

BP0249
478-61-5
98%
Biopurify
Berbamine is a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity and also an inhibitor of NF-κB. Berbamine may be the first ATP-competitive inhibitor of CaMKII γ, could be as a new type of molecular targeted agent through inhibition of the CaMKII γ activity for treatment of leukemia.Berbamine confers cardioprotection against I/R injury by attenuating [Ca(2+)inf(i) overloading and preventing calpain activation through the activation of the PI3K-Akt-GSK3β pathway and, subsequently, opening of the mitoK(ATP) channel. Berbamine is a bisbenzylisoquinoline alkaloid and a member of isoquinolines.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0249-20mg 20mg
BP0249-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Product drug property prediction parameters

  • 72.8600

  • 5.7795

  • 5.1437

  • .0059

  • 4.7215

  • 19.9985

  • Low

  • 91.5576

  • 5.7402

  • No

  • No

  • Yes

  • Yes

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • Yes